Shigenori Kadowaki

32PUBLICATIONS
198CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCellular immunologyPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 31, 2026
Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis.

|Jul 01, 2026
Identification of a Novel GOLGB1-RET Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib.

|Jun 19, 2026
Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with PD-L1 amplification: a case report.

|May 31, 2026
Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

|May 18, 2026
Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors.

|Apr 13, 2026
Development of a visualization tool to estimate out-of-pocket costs for systemic cancer therapy in Japan and claims-based agreement evaluation: the VEST-Ca study.

Kazunori Honda, Kazuhiro Shimomura, Hiroya Taniguchi

Pageof 6

Frequent Collaborators

9 joint publications

Hideaki Bando

9 joint publications

Takayuki Yoshino

7 joint publications

Yoshiaki Nakamura

7 joint publications

Yoshito Komatsu